SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stratajema who wrote (34)3/18/1997 11:55:00 PM
From: Michael G. Potter   of 369
 
David,

The real challenge for Uromed is to get patients to use their product. I've received mixed reactions from the doctors I've asked about it, and I noticed that Uromed is now trying to increase patient awareness instead of just focussing on doctors. Another problem is that insurance does not cover their product and the additional cost may lead to less sales as patients opt for surgery which is covered by insurance

I'm long URMD, but I'm watching them closely. I'm planning on calling them next week to see if I can get some indication of their current patient count to see if it is increasing. I think that the lead to market over Rochester Medical and their other product (the patch) should give them the momentum they need.

Michael
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext